We have evaluated the serum-to-urine ratio, which is significantly and about 6.5-fold higher in CKD patients, and the fractional excretion of renalase, which is 3-fold, but not significantly lower in CKD group. This evidence concerns the gene RNLS and chronic kidney disease.